E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/3/2014 in the Prospect News Investment Grade Daily.

S&P lowers Shoppers Drug

Standard & Poor's said it lowered the long-term corporate credit rating on Shoppers Drug Mart Corp. to BBB from BBB+ and removed the rating from CreditWatch, where it was placed with negative implications in July 2013.

The outlook is stable.

The agency also said it lowered the issue-level rating on the company's unsecured debt to BBB from BBB+ and removed the rating from CreditWatch. This debt remains outstanding, S&P said.

The downgrade and removal from CreditWatch follows Loblaw Cos. Ltd.'s completed acquisition of Shoppers on March 28. S&P said it has now equalized the ratings on the two companies.

Shoppers is now considered a core subsidiary for its 100% owner, Loblaw, the agency said, and the ratings and outlook of the two are directly linked.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.